Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius Sells 175 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Mark Brosius sold 175 shares of the company's stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $387.22, for a total value of $67,763.50. Following the completion of the sale, the senior vice president now owns 533 shares in the company, valued at approximately $206,388.26. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Monday, May 13th, Mark Brosius sold 175 shares of Intuitive Surgical stock. The stock was sold at an average price of $389.16, for a total value of $68,103.00.
• On Thursday, March 7th, Mark Brosius sold 196 shares of Intuitive Surgical stock. The shares were sold at an average price of $393.30, for a total transaction of $77,086.80.
• On Tuesday, March 5th, Mark Brosius sold 196 shares of Intuitive Surgical stock. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00.
• On Friday, February 16th, Mark Brosius sold 32 shares of Intuitive Surgical stock. The stock was sold at an average price of $378.29, for a total transaction of $12,105.28.

Intuitive Surgical Trading Up 4.0 %

Shares of ISRG traded up $15.20 during trading hours on Wednesday, reaching $399.39. 1,200,371 shares of the stock traded hands, compared to its average volume of 1,569,749. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The stock has a fifty day simple moving average of $384.53 and a 200 day simple moving average of $356.07. The company has a market cap of $141.66 billion, a price-to-earnings ratio of 71.34, a PEG ratio of 4.92 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts' consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company's revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.00 EPS. Analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. OFI Invest Asset Management purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth about $25,000. Baystate Wealth Management LLC increased its holdings in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider's stock worth $25,000 after buying an additional 45 shares during the last quarter. MCF Advisors LLC raised its position in Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 40 shares during the period. Headinvest LLC purchased a new position in Intuitive Surgical in the third quarter valued at about $28,000. Finally, Able Wealth Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $28,000. Institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Citigroup increased their price target on Intuitive Surgical from $428.00 to $462.00 and gave the stock a "buy" rating in a report on Wednesday, April 3rd. Mizuho increased their target price on shares of Intuitive Surgical from $350.00 to $390.00 and gave the stock a "neutral" rating in a research note on Thursday, January 25th. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an "outperform" rating in a report on Wednesday, January 24th. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an "overweight" rating in a report on Friday, January 19th. Finally, StockNews.com downgraded Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Thursday, February 29th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.